Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Gareth W. Young

41 indexed publications match this author name.

ORCID
0000-0002-8763-4668
OpenAlex
https://openalex.org/A5080792245

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjectsJournal of Psychopharmacology · 2026-05-28Trials, trips, and tribulations: pathways for implementing psychedelic therapy in IrelandThe International Journal of Neuropsychopharmacology · 2026-05-08Complete biosynthesis of psychedelic tryptamines from three kingdoms in plantsScience Advances · 2026-03-31The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experienceJournal of Psychopharmacology · 2026-01-25The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trialNeuroscience Applied · 2025-12-31Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.Unknown journal · 2025-01-31Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.Unknown journal · 2025-01-29The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionJournal of Psychiatric Research · 2024-10-10B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-11Psilocybin for clinical indications: A scoping review.Unknown journal · 2024-08-12Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseasesUnknown journal · 2024-05-31Is it now time to prepare psychiatry for a psychedelic future?The British Journal of Psychiatry · 2024-05-19Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Unknown journal · 2024-04-05Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatmentNeuroscience Applied · 2023-12-31Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousnessNeuroscience Applied · 2023-12-31Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12Psychedelics for treatment resistant depression: are they game changers?Unknown journal · 2023-08-31Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionUnknown journal · 2023-07-18Psychedelics reopen the social reward learning critical periodNature · 2023-06-13Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020Journal of Psychopharmacology · 2023-03-05Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-29Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.Journal of Psychopharmacology · 2022-04-06The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Psilocybin: From Serendipity to Credibility?Frontiers in Psychiatry · 2021-04-20Complete mitochondrial genome sequence of Gymnopilus junonius.Mitochondrial DNA Part B · 2021-03-17Historic psychedelic drug trials and the treatment of anxiety disorders.Depression and anxiety · 2020-11-30Psychedelic treatment of functional neurological disorder: a systematic review.Unknown journal · 2020-05-10Psychedelics in the treatment of unipolar mood disorders: a systematic review.Unknown journal · 2016-11-16Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.Фундаментальные исследования (Fundamental Research) · 2013-02-28Chemical Constituents of Gymnopilus spectabilis and Their Antioxidant Activity.Mycobiology · 2008-03-30

Author directory

Carhart-Harris RL.59 publicationsRobin Carhart-Harris57 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ50 publicationsJohnson MW44 publicationsErritzoe D43 publicationsRoseman L41 publicationsBarrett FS.34 publicationsDavid Erritzøe34 publicationsDavid Nutt34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsRoland R. Griffiths28 publicationsHendricks PS27 publicationsFranz X. Vollenweider24 publicationsGitte M. Knudsen24 publicationsRosenblat JD24 publicationsGarcia-Romeu A23 publicationsKatrin H. Preller23 publicationsAlbert Garcia-Romeu22 publicationsPatrick M. Fisher22 publicationsPáleníček T.22 publicationsSandeep M. Nayak22 publicationsTomáš Páleníček22 publicationsDea Siggaard Stenbæk21 publicationsFisher PM21 publicationsMatthew W. Johnson21 publicationsDavis AK20 publicationsFrederick S. Barrett20 publicationsMcIntyre RS20 publicationsJames Rucker19 publicationsKargbo RB.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDirk Hoffmeister18 publicationsDos Santos RG18 publicationsHusain MI18 publicationsLiechti ME18 publicationsM. Madsen18 publicationsNathan D. Sepeda18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsGuy M. Goodwin17 publicationsKuypers KPC.17 publicationsSimonsson O17 publicationsBrice Ozenne16 publicationsHannes Kettner16 publicationsKringelbach ML.16 publicationsKwan AC.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsYale University16 publicationsFischer R.15 publicationsGonzález-Maeso J15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsMadsen MK15 publicationsMason NL.15 publicationsMatthias E. Liechti15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsAlan K. Davis14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKim P. C. Kuypers14 publicationsKometer M14 publicationsManish Agrawal14 publicationsMuhammad Ishrat Husain14 publicationsNayak SM14 publicationsBasel13 publicationsDavid J. Hellerstein13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsNatasha L. Mason13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsDavid B. Yaden12 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJoshua Woolley12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMartin Kuchař12 publicationsMcCulloch DE12 publicationsPeter S. Hendricks12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsStephen Ross12 publicationsWang X12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsAlexander M. Sherwood11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsFriederike Holze11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsKaelen M11 publicationsLeor Roseman11 publicationsMichael P. Bogenschutz11 publicationsNichols CD.11 publicationsOsika W11 publicationsRoger S. McIntyre11 publicationsScott T. Aaronson11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsCharles D. Nichols10 publicationsChristopher Timmermann10 publicationsDavoudian PA10 publicationsDrummond E-Wen McCulloch10 publications